Variable | n | Univariate | Multivariate | ||||
OR | 95% CI | p Value | OR | 95% CI | p Value | ||
Gender | |||||||
Male (ref) | 81 | 1 | 1 | ||||
Female | 79 | 2.22 | 1.05 to 4.67 | 0.04 | 2.41 | 1.07 to 5.40 | 0.03 |
Age at diagnosis | |||||||
≤40 years (ref) | 124 | 1 | 1 | ||||
>40 years | 36 | 2.13 | 0.95 to 4.78 | 0.07 | 1.99 | 0.82 to 4.80 | 0.13 |
Education level at diagnosis | |||||||
Missing=14 | |||||||
<12 years (ref) | 87 | 1 | |||||
>12 years | 59 | 1.27 | 0.60 to 2.69 | 0.53 | |||
Smoking at diagnosis | |||||||
Missing=2 | |||||||
Non-smoker (ref) | 88 | 1 | |||||
Smoker | 70 | 1.67 | 0.81 to 3.45 | 0.17 | |||
SR or CRP at diagnosis | |||||||
Missing=5 | |||||||
≤30 (ref) | 49 | 1 | |||||
>30 | 106 | 1.75 | 0.76 to 4.05 | 0.19 | |||
Disease localisation at diagnosis | |||||||
L1 or L4 (ref) | 49 | 1 | |||||
L2 | 70 | 0.63 | 0.27 to 1.47 | 0.28 | |||
L3 | 41 | 0.92 | 0.36 to 2.32 | 0.85 | |||
Disease behaviour at diagnosis | |||||||
B1 (ref) | 97 | 1 | |||||
B2 | 45 | 0.82 | 0.36 to 1.9 | 0.65 | |||
B3 | 18 | 0.82 | 0.25 to 2.73 | 0.75 | |||
Abscess and/or fistula at diagnosis | |||||||
Missing=10 | |||||||
Yes (ref) | 20 | 1 | |||||
No | 130 | 1.02 | 0.34 to 3.03 | 0.97 | |||
Steroid treatment at diagnosis | |||||||
Missing=2 | |||||||
No (ref) | 68 | 1 | |||||
Yes | 90 | 1.40 | 0.66 to 2.97 | 0.38 | |||
Steroid treatment at 1-year follow-up | |||||||
Missing=4 | |||||||
No (ref) | 102 | 1 | 1 | ||||
Yes | 54 | 4.30 | 2.00 to 9.28 | <0.001 | 4.33 | 1.96 to 9.59 | <0.001 |
Number of relapses during 1st year | |||||||
Missing=4 | |||||||
None (ref) | 75 | 1 | |||||
1–2 | 69 | 1.63 | 0.76 to 3.52 | 0.21 | |||
>2 | 12 | 1.33 | 0.32 to 5.54 | 0.69 | |||
Resection before 1-year follow-up | |||||||
No (ref) | 130 | 1 | |||||
Yes | 30 | 0.93 | 0.37 to 2.38 | 0.88 | |||
Mucosal healing at 1-year follow-up | |||||||
Missing=43 | |||||||
Yes (ref) | 56 | 1 | |||||
No | 61 | 1.20 | 0.50 to 2.84 | 0.69 | |||
ASCA | |||||||
Missing=13 | |||||||
Negative (ref) | 103 | 1 | |||||
Positive | 43 | 1.13 | 0.50 to 2.58 | 0.77 |
No work disability, n=121; work disability, n=39.
ASCA, anti-Saccromyces cerevisiae antibodies; Ref, reference category; WD, work disability because IBD (applied for or granted rehabilitation benefits or disability pension).